London, UK, 27 February 2007: BioProgress plc (‘BioProgress’ or the ‘Company’) (AIM: BPRG; NASDAQ: BPRG), the speciality pharmaceutical and healthcare company, is pleased to update the market on the launch of a new pharmaceutical enabling technology, Meltums™.
